| NCT06990529 | Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation | RECRUITING | PHASE2 | 2025-04-29 | 2029-04-13 | 2028-09-18 |
| NCT06897358 | Leniolisib for Immune Dysregulation in CVID | RECRUITING | PHASE2 | 2025-02-12 | 2026-10 | 2026-10 |
| NCT06549114 | Leniolisib for Immune Dysregulation in PIDs | RECRUITING | PHASE2 | 2024-10-21 | 2025-10 | 2025-10 |
| NCT05693129 | Pediatric Patients Aged 1 to 6 Years With APDS | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-08-30 | 2026-02-28 | 2025-04-09 |
| NCT06249997 | An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS | RECRUITING | PHASE3 | 2023-08-03 | 2025-03-31 | 2025-01-31 |
| NCT05438407 | Pediatric Patients Aged 4 to 11 Years With APDS | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-02-01 | 2025-12-30 | 2025-07-28 |
| NCT04912141 | Prevention of Acute Kidney Injury in Patients With NSTEMI | TERMINATED | PHASE2 | 2021-04-21 | 2023-04-28 | 2023-04-28 |
| NCT04530136 | Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 | COMPLETED | PHASE2 | 2020-11-30 | 2021-12-01 | 2021-09-07 |
| NCT02859727 | Extension to the Study of Efficacy of CDZ173 in Patients with APDS/PASLI | TERMINATED | PHASE2, PHASE3 | 2016-09-08 | 2025-01-30 | 2025-01-30 |
| NCT02247739 | A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor | COMPLETED | PHASE2 | 2014-12 | 2016-09 | 2016-05 |
| NCT01359969 | Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients | COMPLETED | PHASE2 | 2012-01-17 | 2017-07-17 | 2017-07-17 |
| NCT01188564 | Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks | COMPLETED | PHASE3 | 2011-01 | 2013-03 | 2012-12 |
| NCT01035593 | Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation | WITHDRAWN | PHASE2 | 2010-12 | 2011-12 | 2011-12 |
| NCT00851409 | A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration | COMPLETED | PHASE2 | 2009-06 | 2010-04 | 2010-03 |
| NCT00225147 | Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema | COMPLETED | PHASE2, PHASE3 | 2005-07 | 2010-01 | 2009-10 |
| NCT00262301 | Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema | COMPLETED | PHASE3 | 2004-06 | 2009-10 | 2009-07 |
| NCT00262288 | Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema | COMPLETED | PHASE2, PHASE3 | 2004-04 | 2007-01 | 2007-01 |
| NCT00261053 | Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema | COMPLETED | PHASE2 | 2003-06 | 2005-12 | 2005-09 |